Transdermal Specialties Global
PrivateCompany Overview
Transdermal Specialties Global operates in Healthcare & Life Sciences and is based in Broomall, Pennsylvania. It was founded in 2004.
Transdermal Specialties Global is a healthcare company that develops patented needle-free ultrasonic transdermal drug delivery systems, including an insulin patch for diabetes management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transdermal Specialties Global Comparables
Compare Transdermal Specialties Global with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NuGen Medical Devices Inc. | 78% | |
| CeQur | 76% | |
| PassPort Technologies, Inc. | 75% |
For institutional investors. Book with your work email.
Transdermal Specialties Global Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 5, 2024
Grew 300% QoQ from 1 to 4 employees.
For institutional investors. Book with your work email.
Transdermal Specialties Global Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Transdermal Specialties Global's valuation, stock price, and market status.
Is Transdermal Specialties Global a public or private company?
Transdermal Specialties Global is a private company.
What is the current stock price of Transdermal Specialties Global?
Transdermal Specialties Global is a private company, so its shares have no public market price. Caplight tracks Transdermal Specialties Global's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Transdermal Specialties Global worth (valuation)?
Valuation information for Transdermal Specialties Global is not publicly available.
Can I buy Transdermal Specialties Global stock?
Transdermal Specialties Global shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Transdermal Specialties Global's last funding round?
Funding round information for Transdermal Specialties Global is not publicly available.
Who are the main investors in Transdermal Specialties Global?
Investor information for Transdermal Specialties Global is not publicly disclosed.
Will Transdermal Specialties Global IPO soon?
No public IPO plans have been announced for Transdermal Specialties Global.
How can I track Transdermal Specialties Global secondary market activity?
Caplight tracks bids, offers, and trades in Transdermal Specialties Global's shares on secondary markets.